Human CHRNB1 activation kit by CRISPRa

CAT#: GA100817

CHRNB1 CRISPRa kit - CRISPR gene activation of human cholinergic receptor nicotinic beta 1 subunit

  See Other Versions


Find the corresponding CRISPRi Inhibitor Kit

USD 1,290.00

2 Weeks*

Size
    • 1 kit

Product Images

Frequently bought together (2)
Goat Anti-CHRNB1 / ACHRB Antibody
    • 100 ug

USD 375.00


qSTAR qPCR primer pairs against Homo sapiens gene CHRNB1
    • 200 reactions

USD 120.00

Other products for "CHRNB1"

Specifications

Product Data
Format 3gRNAs, 1 scramble ctrl and 1 enhancer vector
Symbol CHRNB1
Locus ID 1140
Kit Components

GA100817G1, CHRNB1 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA100817G2, CHRNB1 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA100817G3, CHRNB1 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer The kit is designed based on the best knowledge of CRISPa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_000747
Synonyms ACHRB; CHRNB; CMS1D; CMS2A; CMS2C; SCCMS
Summary 'The muscle acetylcholine receptor is composed of five subunits: two alpha subunits and one beta, one gamma, and one delta subunit. This gene encodes the beta subunit of the acetylcholine receptor. The acetylcholine receptor changes conformation upon acetylcholine binding leading to the opening of an ion-conducting channel across the plasma membrane. Mutations in this gene are associated with slow-channel congenital myasthenic syndrome. [provided by RefSeq, Jul 2008]'

Other Versions

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.